We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Pharmacokinetics of meropenem after intravenous, intramuscular and subcutaneous administration to cats.
- Authors
Albarellos, Gabriela A.; Montoya, Laura; Passini, Sabrina M.; Lupi, Martín P.; Lorenzini, Paula M.; Landoni, María F.
- Abstract
Objectives The aim of the study was to describe the pharmacokinetics and predicted efficacy of meropenem after intravenous (IV), intramuscular (IM) and subcutaneous (SC) administration to cats at a single dose of 10 mg/kg. Methods Five adult healthy cats were used. Blood samples were withdrawn at predetermined times over a 12 h period. Meropenem concentrations were determined by microbiological assay. Pharmacokinetic analyses were performed with computer software. Initial estimates were determined using the residual method and refitted by non-linear regression. The time that plasma concentrations were greater than the minimum inhibitory concentration (T >MIC) was estimated by applying bibliographic MIC values and meropenem MIC breakpoint. Results Maximum plasma concentrations of meropenem were 101.02 µg/ml (Cp(0), IV), 27.21 µg/ml (Cmax, IM) and 15.57 µg/ml (Cmax, SC). Bioavailability was 99.69% (IM) and 96.52 % (SC). Elimination half-lives for the IV, IM and SC administration were 1.35, 2.10 and 2.26 h, respectively. Conclusions and relevance Meropenem, when administered to cats at a dose of 10 mg/kg q12h,, is effective against bacteria with MIC values of 6 μg/ml, 7 μg/ml and 10 μg/ml for IV, IM and SC administration, respectively. However, clinical trials are necessary to confirm clinical efficacy of the proposed dosage regimen.
- Publication
Journal of Feline Medicine & Surgery, 2016, Vol 18, Issue 12, p976
- ISSN
1098-612X
- Publication type
Article
- DOI
10.1177/1098612X15604655